JPRN-UMIN000008090
Completed
Phase 4
A study on the procedure for treatment switch to epoetin beta pegol in the treatment of renal anemia in maintenance hemodialysis patients - A study on the procedure for treatment switch to epoetin beta pegol
Faculty of medicine, University of Miyazaki0 sites30 target enrollmentJune 3, 2012
ConditionsRenal Anemia Patients on Hemodialysis
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Renal Anemia Patients on Hemodialysis
- Sponsor
- Faculty of medicine, University of Miyazaki
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have uncontrollable hypertension Patients with heart failure (NYHA functional class 3 or 4\) Women who are pregnant, breastfeeding, or possibly pregnant. Patients who have known serious allergy or serious drug allergy (shock, anaphylactoid symptoms) Patients who have malignant tumor (including hematologic malignancy), severe infection, systemic hematologic disease (e.g. myelodysplastic syndrome, hemoglobinopathy), hemolytic anemia, or apparent hemorrhagic lesion such as gastrointestinal bleeding Patients who have received CERA before enrollment Patients whose AST or ALT level was100 IU/L or higher in the latest examination before enrollment Patients who received red blood cell transfusion within 16 weeks prior to enrollment Patients who are scheduled for surgery that may cause massive bleeding during the study period Patients who are judged ineligible by the investigator/sub\-investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A clinical trial of introduction and adjustment of insulin Degludec in hospitalized patients with type 2 diabetestype 2 diabetesJPRN-UMIN000035758Department of Diabetes and Endocrinology, Kansai Rosai Hospital34
Recruiting
N/A
The clinical study associated with the treatment effects and effectiveness prediction of subretinal neovascularization lesion.Age-related Macular DegenerationJPRN-UMIN000014436Department of Ophthalmology and Visual Sciences Yamagata100
Recruiting
Phase 1
VECTORS – A study to evaluate transmural healing as a treatment target in Crohn’s diseaseModerately to Severely Active Crohn’s DiseaseMedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]CTIS2023-509096-16-00Alimentiv Inc.266
Completed
Phase 2
Effect of treatment using Takra in the management of Grahani Dosha (Irritable bowel syndrome)CTRI/2021/01/030781All India Institute of Ayurveda
Completed
Phase 2
De-escalation and stopping treatment of imatinib, nilotinib or sprycel in chronic myeloid leukaemiaTopic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (chronic)CancerChronic myelogenous leukaemiaISRCTN74084226niversity of Liverpool (UK)168